0001209191-19-003178.txt : 20190109
0001209191-19-003178.hdr.sgml : 20190109
20190109210924
ACCESSION NUMBER: 0001209191-19-003178
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190103
FILED AS OF DATE: 20190109
DATE AS OF CHANGE: 20190109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ong Tuyen
CENTRAL INDEX KEY: 0001673178
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38217
FILM NUMBER: 19519152
MAIL ADDRESS:
STREET 1: C/O PTC THERAPEUTICS, INC.
STREET 2: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nightstar Therapeutics plc
CENTRAL INDEX KEY: 0001711675
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: C/O NIGHTSTAR, INC.
STREET 2: 203 CRESCENT STREET, SUITE 303
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 781-778-7553
MAIL ADDRESS:
STREET 1: C/O NIGHTSTAR, INC.
STREET 2: 203 CRESCENT STREET, SUITE 303
CITY: WALTHAM
STATE: MA
ZIP: 02453
FORMER COMPANY:
FORMER CONFORMED NAME: Nightstar Therapeutics Ltd
DATE OF NAME CHANGE: 20170712
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2019-01-03
2019-01-07
0
0001711675
Nightstar Therapeutics plc
NITE
0001673178
Ong Tuyen
C/O NIGHTSTAR, INC.
203 CRESCENT STREET, SUITE 303
WALTHAM
MA
02453
0
1
0
0
Chief Development Officer
Ordinary Shares
2019-01-03
4
S
0
4070
12.00
D
85471
D
The ordinary shares, nominal value GBP 0.01 per share, of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents one ordinary share of the Issuer.
This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
The original Form 4 has been amended to include all unvested restricted shares disclosed in the Reporting Person's Form 3 in Column 5 of this Form 4/A. This Form 4/A amends and restates, in its entirety, the original Form 4.
/s/ Bryan Yoon, Attorney-in-Fact
2019-01-09